← Back to all substances
C

lisinopril

285ms
Level 1

✓ What this shows

  • • Reported adverse events from FDA FAERS
  • • Descriptive statistics from a locked corpus
  • • Data verified with cryptographic hashes

✗ What this is NOT

  • • Not medical advice or recommendations
  • • Not proof of causality
  • • Not a complete safety profile

About this substance

Class: Thiazide Diuretic [EPC]

INDICATIONS AND USAGE Lisinopril and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen...

Known as: Lisinopril and Hydrochlorothiazide
Route: ORAL
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
312,918
Total in FDA
64%
Serious Reports
36
Fatal Outcomes

Seriousness

Serious
321
Non-Serious
179

Sex Distribution

Male
228
Female
250
Unknown
22

Age Distribution

18-40
15
41-64
191
65-84
184
85+
19
Unknown
91

Outcomes

Recovered/Resolved
387
Recovering/Resolving
99
Not Recovered/Not Resolved
380
Recovered with Sequelae
17
Fatal
36
Unknown
975

Top Reported Reactions (click to view reports)

Verification Data

Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-8a69f3
ℹThis output reports adverse events from FDA FAERS. It does not constitute medical advice.

Molecular Structure (reference)

Structural visualization for identification only.

This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.

Loading structure...